Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1980;71(1):201–210. doi: 10.1111/j.1476-5381.1980.tb10927.x

Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.

K Jhamandas, M Sutak
PMCID: PMC2044432  PMID: 7470736

Abstract

1 Methionine (Met)-enkephalin, leucine (Leu)-enkephalin and their synthetic analogues were tested for effects on the spontaneous release of cortical acetylcholine (ACh) in vivo. The ability of naloxone to reverse the action of enkephalins on ACh release was compared with its action against morphine. An enkephalin analogue, structurally related to Met-enkephalin, was tested for opiate antagonistic activity in ACh release experiments. 2 Intraventricular administration of Met-enkephalin, Leu-enkephalin, D-Ala2-Met5-enkephalinamide (DALA) and D-Ala2-D-Leu5-enkephalin (DALEU) produced a dose-related inhibition of cortical ACh release. Met- and Leu-enkephalin were very similar both in their potency and the time course of their action on ACh release. Both DALA and DALEU were more potent and had a longer duration of action than Leu-enkephalin. Systemic injections of two pentapeptides, D-Met2-Pro5-enkephalinamide and D-Ala2-MePhe4-Met5(O)-ol-enkephalin (33,824), produced a sustained inhibition of cortical ACh release. 3 Naloxone, administered systemically following the depression of ACh release induced by either intraventricular injections of enkephalins (DALA or DALEU), or systemic injections of enkephalins (D-Met2-Pro5-enkephalinamide or 33,824), reversed this depression and restored the release to baseline levels. The effect of D-Met2-Pro5-enkephalinamide on the release of ACh was reversed by naloxone with difficulty. Naloxone also reversed the inhibitory effect of systemic morphine and this reversal was associated with a large overshoot of ACh release. The latter was never observed in the enkephalin experiments. 4 Intraventricular injection of the pentapeptide, D-Ala2-D-Ala3-Met5-enkephalinamide (TAAPM), at doses that did not influence the basal ACh release, blocked or reversed the inhibitory effect of morphine on this release. This peptide did not block the effect of the non-opiate, chlorpromazine, under similar conditions. In two experiments TAAPM failed to reverse the inhibition of ACh release produced by systemically injected enkephalin, D-Met2-Pro5-enkephalinamide. 5 Effects of morphine and enkephalin on ACh release are discussed in terms of their action on difference opiate receptors.

Full text

PDF
201

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bajusz S., Patthy A., Kenessey A., Gráf L., Székely J. I., Rónai A. Z. Is there correlation between analgesic potency and biodegradation of enkephalin analogs? Biochem Biophys Res Commun. 1978 Oct 30;84(4):1045–1053. doi: 10.1016/0006-291x(78)91689-3. [DOI] [PubMed] [Google Scholar]
  2. Bajusz S., Rónai A. Z., Székely J. I., Gráf L., Dunai-Kovács Z., Berzétei I. A superactive antinociceptive pentapeptide, (D-Met2, Pro5)-enkephalinamide. FEBS Lett. 1977 Apr 1;76(1):91–92. doi: 10.1016/0014-5793(77)80127-0. [DOI] [PubMed] [Google Scholar]
  3. Chang J. K., Fong B. T., Pert A., Pert C. B. Opiate receptor affinities and behavioral effects of enkephalin: structure-activity relationship of ten synthetic peptide analogues. Life Sci. 1976 Jun 15;18(12):1473–1481. doi: 10.1016/0024-3205(76)90366-0. [DOI] [PubMed] [Google Scholar]
  4. Craves F. B., Law P. Y., Hunt C. A., Loh H. H. The metabolic disposition of radiolabeled enkephalins in vitro and in situ. J Pharmacol Exp Ther. 1978 Aug;206(2):492–506. [PubMed] [Google Scholar]
  5. Duggan A. W., Hall J. G., Headley P. M. Enkephalins and dorsal horn neurones of the cat: effects on responses to noxious and innocuous skin stimuli. Br J Pharmacol. 1977 Nov;61(3):399–408. doi: 10.1111/j.1476-5381.1977.tb08432.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hughes J., Smith T. W., Kosterlitz H. W., Fothergill L. A., Morgan B. A., Morris H. R. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature. 1975 Dec 18;258(5536):577–580. doi: 10.1038/258577a0. [DOI] [PubMed] [Google Scholar]
  7. Jessell T. M., Iversen L. L. Opiate analgesics inhibit substance P release from rat trigeminal nucleus. Nature. 1977 Aug 11;268(5620):549–551. doi: 10.1038/268549a0. [DOI] [PubMed] [Google Scholar]
  8. Jhamandas K., Hron V., Sutak M. Comparative effects of opiate agonists methadone, levorphanol, and their isomers on the release of cortical ACh in vivo and in vitro. Can J Physiol Pharmacol. 1975 Aug;53(4):540–548. doi: 10.1139/y75-076. [DOI] [PubMed] [Google Scholar]
  9. Jhamandas K., Sawynok J., Sutak M. Enkephalin effects on release of brain acetylcholine. Nature. 1977 Sep 29;269(5627):433–434. doi: 10.1038/269433a0. [DOI] [PubMed] [Google Scholar]
  10. Jhamandas K., Sutak M. Morphine-naloxone interaction in the central cholinergic system: the influence of subcortical lesioning and electrical stimulation. Br J Pharmacol. 1976 Sep;58(1):101–107. doi: 10.1111/j.1476-5381.1976.tb07697.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lemaire S., Magnan J., Regoli D. Rat vas deferens: a specific bioassay for endogenous opioid peptides. Br J Pharmacol. 1978 Nov;64(3):327–329. doi: 10.1111/j.1476-5381.1978.tb08653.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Leybin L., Pinsky C., LaBella F. S., Havlicek V., Rezek M. Intraventricular Met5-enkephalin causes unexpected lowering of pain threshold and narcotic withdrawal signs in rats. Nature. 1976 Dec 2;264(5585):458–459. doi: 10.1038/264458a0. [DOI] [PubMed] [Google Scholar]
  13. Lord J. A., Waterfield A. A., Hughes J., Kosterlitz H. W. Endogenous opioid peptides: multiple agonists and receptors. Nature. 1977 Jun 9;267(5611):495–499. doi: 10.1038/267495a0. [DOI] [PubMed] [Google Scholar]
  14. Malick J. B., Goldstein J. M. Analgesic activity of enkephalins following intracerebral administration in the rat. Life Sci. 1977 Mar 1;20(5):827–832. doi: 10.1016/0024-3205(77)90034-0. [DOI] [PubMed] [Google Scholar]
  15. Pert C. B., Pert A., Chang J. K., Fong B. T. (D-Ala2)-Met-enkephalinamide: a potent, long-lasting synthetic pentapeptide analgesic. Science. 1976 Oct 15;194(4262):330–332. doi: 10.1126/science.968485. [DOI] [PubMed] [Google Scholar]
  16. Rigter H. Attenuation of amnesia in rats by systemically administered enkephalins. Science. 1978 Apr 7;200(4337):83–85. doi: 10.1126/science.635578. [DOI] [PubMed] [Google Scholar]
  17. Roemer D., Buescher H. H., Hill R. C., Pless J., Bauer W., Cardinaux F., Closse A., Hauser D., Huguenin R. A synthetic enkephalin analogue with prolonged parenteral and oral analgesic activity. Nature. 1977 Aug 11;268(5620):547–549. doi: 10.1038/268547a0. [DOI] [PubMed] [Google Scholar]
  18. Shaw J. S., Turnbull M. J. In vitro profile of some opioid pentapeptide analogues. Eur J Pharmacol. 1978 Jun 1;49(3):313–317. doi: 10.1016/0014-2999(78)90109-7. [DOI] [PubMed] [Google Scholar]
  19. Simantov R., Snyder S. H. Morphine-like peptides, leucine enkephalin and methionine enkephalin: interactions with the opiate receptor. Mol Pharmacol. 1976 Nov;12(6):987–998. [PubMed] [Google Scholar]
  20. Subramanian N., Mitznegg P., Sprügel W., Domschke W., Domschke S., Wünsch E., Demling L. Influence of enkephalin on K+-evoked efflux of putative neurotransmitters in rat brain. Selective inhibition of acetylcholine and dopamine release. Naunyn Schmiedebergs Arch Pharmacol. 1977 Sep;299(2):163–165. doi: 10.1007/BF00498558. [DOI] [PubMed] [Google Scholar]
  21. Taube H. D., Borowski E., Endo T., Starke K. Enkephalin: a potential modulator of noradrenaline release in rat brain. Eur J Pharmacol. 1976 Aug;38(2):377–380. doi: 10.1016/0014-2999(76)90343-5. [DOI] [PubMed] [Google Scholar]
  22. Vaught J. L., Takemori A. E. Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence. J Pharmacol Exp Ther. 1979 Jan;208(1):86–90. [PubMed] [Google Scholar]
  23. Waterfield A. A., Smokcum R. W., Hughes J., Kosterlitz H. W., Henderson G. In vitro pharmacology of the opioid peptides, enkephalins and endorphins. Eur J Pharmacol. 1977 May 15;43(2):107–116. doi: 10.1016/0014-2999(77)90123-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES